ING Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.5M | Buy |
|
|||||
2025
Q1 | $19.2M | Sell |
|
|||||
2024
Q4 | $26.9M | Buy |
|
|||||
2024
Q3 | $19.7M | Sell |
|
|||||
2024
Q2 | $35.1M | Buy |
|
|||||
2024
Q1 | $22M | Sell |
|
|||||
2023
Q4 | $30.2M | Buy |
|
|||||
2023
Q3 | $32.8M | Sell |
|
|||||
2023
Q2 | $52.4M | Sell |
|
|||||
2023
Q1 | $86.3M | Buy |
|
|||||
2022
Q4 | $80M | Buy |
|
|||||
2022
Q3 | $40M | Sell |
|
|||||
2022
Q2 | $53.7M | Buy |
|
|||||
2022
Q1 | $47.8M | Buy |
|
|||||
2021
Q4 | $42.8M | Buy |
|
|||||
2021
Q3 | $20.2M | Sell |
|
|||||
2021
Q2 | $18.5M | Buy |
|
|||||
2021
Q1 | $13.6M | Buy |
|
|||||
2020
Q4 | $13.8M | Buy |
|
|||||
2020
Q3 | $8.23M | Buy |
|
|||||
2020
Q2 | $5.45M | Sell |
|
|||||
2020
Q1 | $10.3M | Sell |
|
|||||
2019
Q4 | $23.1M | Sell |
|
|||||
2019
Q3 | $25.7M | Sell |
|
|||||
2019
Q2 | $58.1M | Buy |
|
|||||
2019
Q1 | $17M | Sell |
|
|||||
2018
Q4 | $38.2M | Sell |
|
|||||
2018
Q3 | $49.3M | Sell |
|
|||||
2018
Q2 | $41.1M | Buy |
|
|||||
2018
Q1 | $15M | Sell |
|
|||||
2017
Q4 | $39.2M | Sell |
|
|||||
2017
Q3 | $73.6M | Buy |
|
|||||
2017
Q2 | $31.1M | Buy |
|
|||||
2017
Q1 | $14.1M | Sell |
|
|||||
2016
Q4 | $62.8M | Sell |
|
|||||
2016
Q3 | $73.9M | Sell |
|
|||||
2016
Q2 | $142M | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $244M | Buy |
|
|||||
2015
Q3 | $235M | Sell |
|
|||||
2015
Q2 | $266M | Sell |
|
|||||
2015
Q1 | $276M | Sell |
|
|||||
2014
Q4 | $350M | Sell |
|
|||||
2014
Q3 | $471M | Sell |
|
|||||
2014
Q2 | $489M | Buy |
|
|||||
2014
Q1 | $419M | Buy |
|
|||||
2013
Q4 | $241M | Sell |
|
|||||
2013
Q3 | $229M | Sell |
|
|||||
2013
Q2 | $246M | Buy |
|